Loading...

Nass Valley Gateway

CNSX:NVG
Snowflake Description

Adequate balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
NVG
CNSX
CA$9M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Nass Valley Gateway Ltd. operates as a healthcare company in the United States and internationally. More info.


Add to Portfolio Compare Print
NVG Share Price and Events
7 Day Returns
-70%
CNSX:NVG
-3.5%
CA Pharmaceuticals
0.4%
CA Market
1 Year Returns
-
CNSX:NVG
-1%
CA Pharmaceuticals
-1.9%
CA Market
NVG Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Nass Valley Gateway (NVG) -70% -66.7% -77.8% - - -
CA Pharmaceuticals -3.5% -11.2% -31% -1% 502.4% 420.6%
CA Market 0.4% -0% -1.7% -1.9% 8.3% -0.3%
1 Year Return vs Industry and Market
  • No trading data on NVG.
  • No trading data on NVG.
Price Volatility
Industry
5yr Volatility vs Market

NVG Value

 Is Nass Valley Gateway undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Nass Valley Gateway is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Nass Valley Gateway has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Nass Valley Gateway. This is due to cash flow or dividend data being unavailable. The share price is CA$0.03.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Nass Valley Gateway's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Nass Valley Gateway's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:NVG PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings () in CAD Not available
CNSX:NVG Share Price ** CNSX (2019-07-23) in CAD CA$0.03
Canada Pharmaceuticals Industry PE Ratio Median Figure of 11 Publicly-Listed Pharmaceuticals Companies 19.14x
Canada Market PE Ratio Median Figure of 538 Publicly-Listed Companies 15.38x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Nass Valley Gateway.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to compare the PE ratio to the industry average as no data exists.
  • Unable to calculate PE ratio for Nass Valley Gateway, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Nass Valley Gateway's expected growth come at a high price?
Raw Data
CNSX:NVG PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 0x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.24x
Canada Market PEG Ratio Median Figure of 248 Publicly-Listed Companies 1.22x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Nass Valley Gateway, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Nass Valley Gateway's assets?
Raw Data
CNSX:NVG PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings () in CAD Not available
CNSX:NVG Share Price * CNSX (2019-07-23) in CAD CA$0.03
Canada Pharmaceuticals Industry PB Ratio Median Figure of 145 Publicly-Listed Pharmaceuticals Companies 2.25x
Canada Market PB Ratio Median Figure of 2,445 Publicly-Listed Companies 1.47x

* Primary Listing of Nass Valley Gateway.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to compare the PB ratio to the industry average as no data exists.

Next steps:

  1. Examine Nass Valley Gateway's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Nass Valley Gateway's regulatory filings and announcements.
  3. Show me more potentially undervalued companies in the Pharmaceuticals industry
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess Nass Valley Gateway's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Nass Valley Gateway has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

NVG Future Performance

 How is Nass Valley Gateway expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nass Valley Gateway has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
93.8%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Nass Valley Gateway expected to grow at an attractive rate?
  • Unable to compare Nass Valley Gateway's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Nass Valley Gateway's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Nass Valley Gateway's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:NVG Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 93.8%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 53.8%
Canada Market Earnings Growth Rate Market Cap Weighted Average 14.5%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:NVG Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings () See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Nass Valley Gateway is high growth as no earnings estimate data is available.
  • Unable to determine if Nass Valley Gateway is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:NVG Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings () See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Nass Valley Gateway Company Filings, last reported , and in Trailing twelve months (TTM) annual period rather than quarterly.

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Nass Valley Gateway will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Nass Valley Gateway's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Nass Valley Gateway's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. Nass Valley Gateway's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Nass Valley Gateway's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Nass Valley Gateway has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

NVG Past Performance

  How has Nass Valley Gateway performed over the past 5 years?

In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Nass Valley Gateway has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data. You can see them here.

Show me the analysis anyway

  • No data on Nass Valley Gateway's last earnings update.
The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Nass Valley Gateway's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Insufficient past earnings data to establish if Nass Valley Gateway's year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Nass Valley Gateway's 1-year growth to the 5-year average as past earnings data has not been reported.
  • Unable to compare Nass Valley Gateway's 1-year growth to the CA Pharmaceuticals industry average as past earnings data has not been reported.
Earnings and Revenue History
Nass Valley Gateway's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Nass Valley Gateway Company Filings, last reported , and in Trailing twelve months (TTM) annual period rather than quarterly.

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Unable to establish if Nass Valley Gateway has efficiently used shareholders’ funds last year as no Return on Equity data is available.
  • Unable to establish if Nass Valley Gateway has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as past financial data has not been reported.
  • Unable to establish if Nass Valley Gateway improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.

Next steps:

  1. Examine Nass Valley Gateway'sNass Valley Gateway's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Past financial records are usually unavailable for companies that have just been established or recently publicly listed, which makes them inherently riskier. Take a look at a list of well-established companies here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Past performance checks
We assess Nass Valley Gateway's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Nass Valley Gateway has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

NVG Health

 How is Nass Valley Gateway's financial health and their level of debt?

In this section we usually analyse Nass Valley Gateway's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Nass Valley Gateway has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information. You can see them here.

Show me the analysis anyway

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Nass Valley Gateway's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Unable to compare short term assets to short term liabilities as Nass Valley Gateway has not reported sufficient balance sheet data.
  • Unable to establish if Nass Valley Gateway's long term commitments exceed its cash and other short term assets as Nass Valley Gateway has not reported sufficient balance sheet data.
Balance sheet
This treemap shows a more detailed breakdown of Nass Valley Gateway's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Unable to establish if Nass Valley Gateway has a high level of physical assets or inventory without balance sheet data.
  • Nass Valley Gateway has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Nass Valley Gateway Company Filings, last reported .

  • Nass Valley Gateway has no debt.
  • Nass Valley Gateway has not taken on any debt in the past 5 years.
  • Nass Valley Gateway has no debt, it does not need to be covered by operating cash flow.
  • Nass Valley Gateway has no debt, therefore coverage of interest payments is not a concern.

Next steps:

  1. Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. Nass Valley Gateway's cash and debt levels may be found in its annual reports archived here.
  2. Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Nass Valley Gateway's financial data was last updated here.
  3. Companies with strong financial health are considered a less risky investment. Discover these stocks here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Financial health checks
We assess Nass Valley Gateway's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Nass Valley Gateway has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

NVG Dividends

 What is Nass Valley Gateway's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Nass Valley Gateway dividends.
If you bought CA$2,000 of Nass Valley Gateway shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Nass Valley Gateway's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Nass Valley Gateway's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:NVG Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 337 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2.1%
Canada Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Nass Valley Gateway has not reported any payouts.
  • Unable to verify if Nass Valley Gateway's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Nass Valley Gateway's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Nass Valley Gateway has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Nass Valley Gateway's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Nass Valley Gateway afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Nass Valley Gateway has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

NVG Management

 What is the CEO of Nass Valley Gateway's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
John Affenita
TENURE AS CEO 0.3 years
CEO Bio

Mr. John Peter Affenita has been Chief Executive Officer and Director of Nass Valley Gateway Ltd. since March 2019 and also serves as its President. Mr. Affenita is also the CEO of Nass Valley's acquired subsidiary Pro-Thotics Technology Inc., a position he has held since 2000. Mr. Affenita is the founder of Pro-Thotics Technology, Inc. He is an ABC (American Board of Certification) Orthotist and Prosthetist ("O&P") member, serving the O&P field for 20 years.

CEO Compensation
  • Insufficient data for John to compare compensation growth.
  • Insufficient data for John to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team

John Affenita

TITLE
President
TENURE
0.3 yrs

Michael Semler

TITLE
CFO & Director
TENURE
0.3 yrs
Board of Directors

John Affenita

TITLE
President
TENURE
0.3 yrs

Michael Semler

TITLE
CFO & Director

Darren Palestine

TITLE
Director
TENURE
0.2 yrs

Armand Assante

TITLE
Independent Director
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
09. Apr 19 Buy Dieter Peter Individual 09. Apr 19 09. Apr 19 45,000 CA$0.19 CA$8,550
03. Apr 19 Buy Dieter Peter Individual 29. Mar 19 01. Apr 19 58,000 CA$0.28 CA$13,078
X
Management checks
We assess Nass Valley Gateway's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Nass Valley Gateway has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

NVG News

Simply Wall St News

NVG Company Info

Description

Nass Valley Gateway Ltd. operates as a healthcare company in the United States and internationally. It produces and markets cannabidiol (CBD) products without tetrahydrocannabinol content for internal use, including CBD infused skin, bath, and body care products. The company also sells durable medical equipment products. The company is based in Vancouver, Canada.

Details
Name: Nass Valley Gateway Ltd.
NVG
Exchange: CNSX
Founded:
CA$9,379,784
312,659,477
Website: http://www.nassvalleygateway.com
Address: Nass Valley Gateway Ltd.
422 Richards Street,
Suite 170,
Vancouver,
British Columbia, V6B 2Z4,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX NVG Common Shares Canadian National Stock Exchange CA CAD 20. Mar 2019
DB 3NVN Common Shares Deutsche Boerse AG DE EUR 20. Mar 2019
Number of employees
Current staff
Staff numbers
0
Nass Valley Gateway employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/24 03:26
End of day share price update: 2019/07/23 00:00
Last earnings filing: N/A
Last earnings reported: N/A
Last annual earnings reported: N/A


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.